MedTech

Building the future of connected MedTech

Boutique innovation at global scale

The global digital health market is projected to reach $1.2 trillion by 2032. Half of all US hospitals have adopted connected health solutions for remote monitoring, and over 650 million patients already use digital health tools.

However, for all its promise, MedTech is uniquely challenging. MedTech devices, Software as a Medical Device (SaMD) and advanced medical device software are among the most complex products ever built, combining precision hardware, embedded software, and rigorous compliance. Yet they must remain intuitive for patients and clinicians.

As the industry evolves, discrete devices are transforming into intelligent medical systems, requiring excellence in engineering, data, and design. Capgemini partners with MedTech leaders to modernize devices, accelerate development, and ensure compliance, enabling innovation without compromise.

As the future of connected MedTech continues to take shape, Capgemini is your partner to innovate, build new capabilities, and scale globally.

Client stories

Key challenges and solutions

Modernizing legacy devices

Challenges: Digital experience, compliance, cybersecurity

Legacy equipment often operates in isolation, limiting real-time insights. By embedding connectivity, MedTech leaders can extend product life and unlock new revenue through subscriptions, software upgrades, and enhanced patient engagement.

Challenges: Interoperability, data governance, scaling globally

Connectivity is just the start. Devices must share data seamlessly, integrate with clinical workflows, and deliver optimized experiences.

Challenges: Business model shifts, data quality, customer adoption

Intelligent medical systems provide data-driven insights, which change the payment model from a one-time-payment to subscription-based offerings that deliver ongoing value.

Challenges: Connectivity gaps, patient engagement, regulatory compliance

From digital surgical planning to AI-driven modeling, virtual care integrates devices, data, and services for personalized, home-based care.

Challenges: Disruptions, traceability, regulatory pressure, ESG requirements

MedTech supply chains must be resilient, transparent, and sustainable. By applying real‑time visibility, digital twins, and predictive analytics, manufacturers can anticipate disruptions, ensure end‑to‑end traceability, reduce environmental impact, and maintain continuity from supplier to patient.

Challenges: Data silos, trust in AI decisions, compliance, scaling intelligence

MedTech innovation depends on turning complex data into action. By building trusted data foundations and deploying agentic AI, organizations can automate decisions, optimize operations, and accelerate innovation – while remaining explainable, compliant, and patient‑centric.

Our commitment

How are MedTech leaders managing such a wide range of challenges? Trying to go it alone in-house carries significant risk, as attention and funds are siphoned away from core projects to meet a never-ending list of urgent needs.

But outsourcing comes with risks too. It means entrusting key functions to multiple service providers – outside consultants that may not share your values and priorities, and who may change their conditions, go out of business, or simply fail. Capgemini offers a different solution: a partnership model that aligns our incentives with your goals, so that your success is our success. We bring experience in engineering, data and design, and above all – we bring experience in putting the pieces together.

“Turning MedTech innovation into real-world impact takes more than technology alone. It takes the right partner to bring together design, engineering, data and AI in ways that are safe, scalable and compliant.

Thorsten Rall, Global Life Sciences Industry Lead, Capgemini

Let’s build the future of connected MedTech.

    Design‑led innovation for MedTech

    frog, part of Capgemini Invent

    Transforming MedTech experiences through design, insight, and innovation with frog, part of Capgemini Invent.

    Engineering breakthrough technologies for MedTech

    Cambridge Consultants

    Deep technology expertise and breakthrough innovation from Cambridge Consultants to accelerate MedTech development.

    AI-led optimization at scale

    WNS

    AI- and analytics-led services from WNS that optimize operations, strengthen compliance, and improve patient outcomes.

    Industrial design, mechanical engineering and electronics design

    D+I, part of Capgemini Engineering

    D+I, part of Capgemini Engineering, combines deep technical expertise, beautiful design, and optimized usability.

    From idea to intelligent product, faster

    Synapse, part of Capgemini Invent

    Synapse, part of Capgemini Invent, designs, engineers, and scales connected medical products with real-world impact.

      Meet our experts

      Thorsten Rall

      Thorsten Rall

      Global Industry Lead Life Sciences, EVP
      Since January 2023, Thorsten has been the Executive Vice President and Global Industry Lead for Life Sciences at Capgemini. Previously, he worked at Novartis in various senior roles. As Senior Vice President of Digital Transformation & Innovation, he led the digital function, developed and implemented high-risk, high-return strategic innovation initiatives, and was responsible for Business Development and partnerships in the digital space.

        FAQ

        Capgemini has extensive experience in MedTech and regulated environments. Our teams work within ISO 13485, IEC 62304, FDA, and MDR frameworks to ensure compliance and quality at every stage.

        Capgemini ensures regulatory compliance throughout the entire intelligent medical product lifecycle by embedding quality and regulatory standards into our processes – from concept and design to validation, manufacturing support, and post-market activities.

        Capgemini accelerates time-to-market without compromising safety or quality by embedding compliance into all MedTech solutions.  Capgemini’s methodologies, digital accelerators, and agile practices are all designed for regulated environments at their core.

        Capgemini offers full capabilities for software development in medical devices, including embedded systems, Software as a Medical Device (SaMD), cloud integration, and cybersecurity solutions.

        Capgemini supports innovation while managing risk by combining advanced technologies – such as AI, IoT, and digital twins – with robust risk management frameworks that meet regulatory and safety requirements.

        What differentiates Capgemini is our experience, our partnership model, and our ability to deliver end-to-end medical device engineering – from concept and design through development, validation, regulatory compliance, and lifecycle management – within a single, integrated model.